Key result
Women undergoing PCI with contemporary drug-coated balloons had a higher rate of MACCE at 12 months compared to men.
Why the study?
Data on sex-specific clinical outcomes following PCI with contemporary drug-coated balloons remain limited.
Do clinical outcomes, including MACCE and target lesion failure, differ between women and men undergoing percutaneous coronary intervention with contemporary drug-coated balloons?
Cohort (n=550)
Do clinical outcomes, including MACCE and target lesion failure, differ between women and men undergoing percutaneous coronary intervention with contemporary drug-coated balloons?
Women undergoing PCI with contemporary drug-coated balloons experience significantly higher rates of MACCE and target lesion failure at 12 months compared to men.
Answers are grounded in this paper and cite their sources.
Higher MACCE in women after DCB PCI warrants caution; hypothesis-generating for sex-specific strategies in future trials.
Background Sex-specific differences in clinical outcomes following percutaneous coronary interventions (PCI) with drug-eluting stents (DES) have been previously described, with women showing an increased risk of early myocardial infarction but a lower risk for repeat revascularization. Yet, data on sex-specific outcomes following PCI with contemporary drug-coated balloons (DCB) remain limited. Purpose To assess major adverse cardiac and cerebrovascular events (MACCE) and target lesion failure (TLF) in women and men undergoing PCI with contemporary DCBs. Methods We analyzed consecutive patients who underwent PCI from the ongoing prospective SIROOP registry (NCT:04988685). Primary endpoint was MACCE (a composite of cardiovascular death, myocardial infarction and cerebrovascular events). Secondary outcomes included each component of the primary endpoint, target lesion revascularization (TLR) and target vessel myocardial infarction (TV-MI). All outcomes were independently reviewed. Results A total of 550 patients were included, comprising 93 women (17%) and 456 men (83%). Women were significantly older than men (69±12 vs. 66±10 years, p<0.05). A total of 37% of patients presented with acute coronary syndrome (ACS), 24% had in-stent restenosis, 8% chronic total occlusions, and 55% moderate to severe calcifications. Procedural complications (e.g., coronary dissection, perforation) were similar between sexes. At 12-month follow-up, the rate of MACCE was significantly higher in women compared to men (20% vs. 8.3%, p=0.009). This was primarily driven by a higher TLF rate among women. (see figure) Conclusions In this real-world PCI cohort, women exhibited worse outcomes following PCI with contemporary DCBs, particularly in terms of increased TLF rates. These findings suggest the need for further investigation in dedicated trials to better understand the mechanisms underlying these sex-specific differences and to optimize PCI strategies for women. (Of note, this abstract summarizes early results. Data analysis is ongoing. If accepted, we aim to present data of 1000 patients.)
No takes yet. Share an insight, caveat, or question.
Stutz et al. (2025) conducted a cohort in Percutaneous coronary interventions (PCI) (n=550). Female sex vs. Male sex was evaluated on MACCE (a composite of cardiovascular death, myocardial infarction and cerebrovascular events) (p=0.009). Women undergoing PCI with contemporary drug-coated balloons had a higher rate of MACCE at 12 months compared to men.
Synapse has enriched 10 related papers. Consider them for comparative context: